from The Epoch Times:
Novavax’s shot, which targets the JN.1 variant, has been authorized.
The U.S. Food and Drug Administration (FDA) has authorized a new COVID-19 vaccine from Novavax, giving Americans an alternative to shots from Moderna and Pfizer.
Novavax’s protein-based vaccine will be available soon after regulators granted emergency authorization to the Maryland-based company for the product.
FDA officials said that animal testing data supported the decision.
TRUTH LIVES on at https://sgtreport.tv/
Critics say that the agency should not be making an assertion about safety and effectiveness in the absence of clinical trial data.
“The assertion rings hollow when FDA has not required manufacturers of the mRNA biological [products] to provide scientific evidence to the public that safety and effectiveness has been demonstrated,” Barbara Loe Fisher, co-founder and president of the National Vaccine Information Center, told The Epoch Times previously via email.
JN.1 was displaced in the spring by KP.3 and other variants, according to sequencing performed by the U.S. Centers for Disease Control and Prevention.
The Pfizer and Moderna vaccines target KP.3.
